Prostate Cancer News on BioPortfolio

Articles Patientreported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castrationnaive prostate cancer LATITUDE an international randomised phase 3 trial

The addition of abiraterone acetate plus prednisone to ADT in patients with newly diagnosed highrisk metastatic castrationnaive prostate cancer improved overall PROs by consistently showing a clinical benefit in the progression of pain prostate cancer symp...

ANGLE plc Prostate cancer ARV7 treatment biomarker

GUILDFORD SURREY Marketwired 010818 AIM AG OTCQX ANPCY ANGLE plc "the Company" RESEARCH DEMONSTRATES USE OF PARSORTIXÂ LIQUID BIOPSY TO DETECT ARV7 IN PROSTATE CANCER AS A TREATMENT SELECTION BIOMARKER Parsortixbased ARV7 test may provide a...

Blisters in disguise

A 77 year old man with a history of hypertension angina pectoris chronic obstructive pulmonary disease and prostate hyperplasia presented to the dermatology department with a 6 month history of...

Pages